Literature DB >> 15763284

In vitro investigation of the indirect pathogenicity of beta-lactamase-producing microorganisms in the nasopharyngeal microflora.

Satoru Kaieda1, Hisakazu Yano, Naohiro Okitsu, Yoshio Hosaka, Ryoichi Okamoto, Matsuhisa Inoue, Haruo Takahashi.   

Abstract

OBJECTIVE: Nasopharyngeal microflora contains some beta-lactamase-producing microorganisms. In this study, we investigated in vitro on the indirect pathogenicities of Haemophilus parainfluenzae (H. parainfluenzae) and Moraxella catarrhalis (M. catarrhalis) against the antipneumococcul activities of some beta-lactams.
METHODS: We compared the antimicrobial and bactericidal activities of beta-lactams against penicillin-susceptible Streptococcus pneumoniae (PSSP) with or without presence of the enzymes of two species of beta-lactamase-producing microorganisms, H. parainfluenzae and M. catarrhalis.
RESULTS: When adding the enzymes extracted from these two beta-lactamase-producing microorganisms in equivalent amounts of 10(7) CFU/spot, the minimum inhibitory concentrations of amoxicillin (AMPC) and cefaclor (CCL) increased to >64 microg/mL. Even third-generation cephalosporins, such as cefditren (CDTR) and ceftriaxone (CTRX) showed marked increases with the enzyme of M. catarrhalis. In time-kill kinetics, same phenomenon was observed in mixed culture indicating the indirect pathogenicities of distinct bacteria, not extracted enzymes, on the cidal activities of beta-lactams against PSSP. Clavulanic acid (CVA)/AMPC, faropenem (FRPM), and imipenem (IPM) were not affected by these beta-lactamase-producing strains with respect to their activities against PSSP. However, these two beta-lactamase-producing strains and their enzymes did not show any significant influence on the antipneumococcul activities of beta-lactams, until the number of bacterial cells reached >10(8) CFU/mL.
CONCLUSION: Our results suggest that these two species of beta-lactamase-producing microorganisms in the nasopharyngeal microflora may act as indirect pathogens on the antipneumococcul activities of beta-lactams with reflecting their substrate profiles, but this is dependent on sufficient amounts of enzyme for their influence as indirect pathogens.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15763284     DOI: 10.1016/j.ijporl.2004.11.013

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  5 in total

1.  Influences of biofilm structure and antibiotic resistance mechanisms on indirect pathogenicity in a model polymicrobial biofilm.

Authors:  Heather A O'Connell; Greg S Kottkamp; James L Eppelbaum; Bryan A Stubblefield; Sarah E Gilbert; Eric S Gilbert
Journal:  Appl Environ Microbiol       Date:  2006-07       Impact factor: 4.792

2.  Residence of Streptococcus pneumoniae and Moraxella catarrhalis within polymicrobial biofilm promotes antibiotic resistance and bacterial persistence in vivo.

Authors:  Antonia C Perez; Bing Pang; Lauren B King; Li Tan; Kyle A Murrah; Jennifer L Reimche; John T Wren; Stephen H Richardson; Uma Ghandi; W Edward Swords
Journal:  Pathog Dis       Date:  2014-02-03       Impact factor: 3.166

Review 3.  A Moraxella catarrhalis vaccine to protect against otitis media and exacerbations of COPD: An update on current progress and challenges.

Authors:  Antonia C Perez; Timothy F Murphy
Journal:  Hum Vaccin Immunother       Date:  2017-10-03       Impact factor: 3.452

4.  Longitudinal nasopharyngeal carriage and antibiotic resistance of respiratory bacteria in indigenous Australian and Alaska native children with bronchiectasis.

Authors:  Kim M Hare; Rosalyn J Singleton; Keith Grimwood; Patricia C Valery; Allen C Cheng; Peter S Morris; Amanda J Leach; Heidi C Smith-Vaughan; Mark Chatfield; Greg Redding; Alisa L Reasonover; Gabrielle B McCallum; Lori Chikoyak; Malcolm I McDonald; Ngiare Brown; Paul J Torzillo; Anne B Chang
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

Review 5.  Potential targets for next generation antimicrobial glycoconjugate vaccines.

Authors:  Francesca Micoli; Paolo Costantino; Roberto Adamo
Journal:  FEMS Microbiol Rev       Date:  2018-05-01       Impact factor: 16.408

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.